These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 28693799)
1. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing. Ryan E; Sheahan K; Creavin B; Mohan HM; Winter DC Crit Rev Oncol Hematol; 2017 Aug; 116():38-57. PubMed ID: 28693799 [TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
3. Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. Funkhouser WK; Lubin IM; Monzon FA; Zehnbauer BA; Evans JP; Ogino S; Nowak JA J Mol Diagn; 2012; 14(2):91-103. PubMed ID: 22260991 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome. Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N; Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability testing and its role in the management of colorectal cancer. Kawakami H; Zaanan A; Sinicrope FA Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544 [TBL] [Abstract][Full Text] [Related]
6. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
8. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer. Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature. Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176 [TBL] [Abstract][Full Text] [Related]
11. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113 [TBL] [Abstract][Full Text] [Related]
12. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors. Svrcek M; Lascols O; Cohen R; Collura A; Jonchère V; Fléjou JF; Buhard O; Duval A Bull Cancer; 2019 Feb; 106(2):119-128. PubMed ID: 30713006 [TBL] [Abstract][Full Text] [Related]
14. An Insight into Deficient Mismatch Repair Colorectal Cancer Screening in a Romanian Population-A Bi-Institutional Pilot Study. Lungulescu C; Croitoru VM; Volovat SR; Cazacu IM; Turcu-Stiolica A; Gheonea DI; Sur D; Lungulescu CV Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441055 [No Abstract] [Full Text] [Related]
15. Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas. Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041 [TBL] [Abstract][Full Text] [Related]
16. BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome. Toon CW; Walsh MD; Chou A; Capper D; Clarkson A; Sioson L; Clarke S; Mead S; Walters RJ; Clendenning M; Rosty C; Young JP; Win AK; Hopper JL; Crook A; von Deimling A; Jenkins MA; Buchanan DD; Gill AJ Am J Surg Pathol; 2013 Oct; 37(10):1592-602. PubMed ID: 23797718 [TBL] [Abstract][Full Text] [Related]
17. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time? Søreide K Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726 [TBL] [Abstract][Full Text] [Related]
18. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Bellizzi AM; Frankel WL Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131 [TBL] [Abstract][Full Text] [Related]
20. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]